ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Article

Hospital and patient influencing factors of treatment schemes given to type 2 diabetes mellitus inpatients in Inner Mongolia, China

[version 1; peer review: 2 approved]
PUBLISHED 05 Jul 2016
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

Background:
In clinical practice, the physician’s treatment decision making is influenced by many factors besides the patient’s clinical conditions and is the fundamental cause of healthcare inequity and discrimination in healthcare settings. Type 2 diabetes mellitus (T2DM) is a chronic disease with high prevalence, long average length of stay and high hospitalization rate. Although the treatment of T2DM is well guideline driven, there is a large body of evidence showing the existence of treatment disparities. More empirical studies from the provider side are needed to determine if non-clinical factors influence physician’s treatment choices.
 
Objective:
To determine the hospital and patient influencing factors of treatment schemes given to T2DM inpatients in Inner Mongolia, China.
 
Methods:
A cross-sectional, hospital-based survey using a cluster sampling technique was conducted in three tertiary hospitals and three county hospitals in Inner Mongolia, China. Treatment schemes were categorized as lifestyle management, oral therapy or insulin therapy according to the national guideline. Socio-demographic characteristics and variables related to severity of disease at the individual level and hospital level were collected. Weighted multinomial logistic regression models were used to determine influencing factors of treatment schemes.
 
Results:
Regardless of patients’ clinical conditions and health insurance types, both hospital and patient level variables were associated with treatment schemes. Males were more likely to be given oral therapy (RRR=1.72, 95% CI=1.06-2.81) and insulin therapy (RRR=1.94, 95% CI=1.29-2.91) compared to females who were given lifestyle management more frequently. Compared to the western region, hospitals in the central regions of Inner Mongolia were less likely to prescribe T2DM patients oral therapy (RRR = 0.18, 95% CI=0.05-0.61) and insulin therapy (RRR = 0.20, 95% CI=0.06-0.67) than lifestyle management. Compared with non-reformed tertiary hospitals, reformed tertiary hospitals and county hospitals were less likely to give T2DM patients oral therapy (RRR = 0.07 and 0.1 respectively) and insulin therapy (RRR = 0.11 and 0.17 respectively).
 
Conclusion:
Gender was the only socio-demographic factors associated with treatment scheme for T2DM patients. Hospitals from different regions have different T2DM treatment patterns. Implementation of reform was shown to be associated with controlling medication use for T2DM inpatients. Further studies are needed to investigate the causes of unreasonable treatment disparities so that policies can be generated accordingly.

Keywords

Treatment scheme, healthcare disparities, T2DM, influence factors, hospital management

Introduction

Providing equitable and high quality healthcare is an essential objective of the health systems all over the world. However, variations in medical practices are observed across and within countries1,2 in the management of many diseases and clinical conditions3,4, including diagnosis, nursing care and treatment5.

The differences in healthcare among different population groups are defined as healthcare disparities6. More and more attention is now focused on health disparities that impair healthcare quality and overall health outcomes. It is estimated that $309 billion per year is lost due to the direct and indirect costs of health disparities in the United States of America7.

Both clinical and non-clinical factors may lead to disparities in healthcare. From the view of healthcare equity, it is important to recognize the wide range of factors that contribute to disparities, especially non-clinical factors, such as socio-economic and healthcare system factors. Evidence from the population side suggests that a variety of factors are related to unequal health services received by people810. Although the influencing factors differ among countries and regions, demographic and socio-economic factors are proposed in many studies11,12. Since the clinical conditions of the people are very difficult to evaluate from most population-based surveys by self-reported health status, there are biases when comparisons of treatments are made between different population groups. A hospital-based study may overcome this limitation and provide physicians defined clinical and non-clinical patient information, so that they have more confidence in comparing the healthcare services they receive. Yet evidence from the provider side is limited, especially in low- and middle-income counties13.

Inner Mongolia is a self-governed province located in the northern part of China. Compared to other parts of China, healthcare accessibility is inferior in Inner Mongolia because of the low population density, limited health resources and underdeveloped social-economic status. All of these characteristics may promote healthcare disparities.

Diabetes has become a large and rapidly-growing health problem. In 2011, it accounted for 8.2% of global all-cause mortality of people aged 20–7914. Type 2 diabetes mellitus (T2DM) is one of the leading chronic diseases in Inner Mongolia. The prevalence of diabetes in Inner Mongolia was 2.6% in 2008, according to the fourth National Health Service survey, an increase of 160% from 200315. Besides having a high prevalence, diabetes is also associated with longer length of stay (LOS) in hospital and incurs a high medical expenditure. According to the data of Health Ministry of China in the year 2010 the average LOS of diabetes inpatients was 13.2 days, which was 3.2 days longer than the average LOS of all inpatients16. Healthcare disparities may exist in treatment of T2DM inpatients since the disease is chronic and more expensive than other diseases.

Treatment of T2DM is well guideline-driven. The Chinese Diabetes Society (CDS) issued the Chinese Guideline for Treatment of T2DM and has revised it every 3 to 4 years17. The International Diabetes Federation (IDF) and the American Diabetes Association (ADA) provide updated guidelines for T2DM treatment as well18. Treatment schemes in all the T2DM treatment guidelines consistently include three components: lifestyle management, oral therapy and insulin therapy17,19. Since type 2 diabetes is a progressive disease, patients who have had a longer duration of disease are likely to have reduced beta-cell function and require more intensive therapy compared to patients with a more recently diagnosed disease20.

A hospital-based study was implemented aiming to determine the hospital and patient influencing factors on treatment schemes given to T2DM inpatients in Inner Mongolia of China. Both clinical and non-clinical factors from hospital and patient perspectives were considered. The potential influencing factors considered in this study were categorized as socio-demographic (non-clinical factors in patient side), disease characteristics (clinical factors in hospital side) and hospital characteristics (non-clinical factors in hospital side).

Methods

Study design

A cross-sectional hospital-based study.

Setting and participants

The population of this study comprised T2DM inpatients in Inner Mongolia of China. Inner Mongolia has three-tier hospitals. Tertiary hospitals located in urban area serve both urban and rural people. County hospitals are secondary hospitals serving rural people mostly. Community health institutions and township hospitals provide primary healthcare in urban and rural areas respectively. Moreover, there are Mongolian hospitals included in the hospital system of Inner Mongolia that mainly serve minority people and use totally different techniques and drugs from western medicine. Tertiary and county hospitals, as major providers of T2DM hospitalization care in Inner Mongolia, were chosen for this study. A multistage cluster sampling method was used to select the study sample. Inner Mongolia was geographically classified into three regions and the largest tertiary hospital and county hospital in each region were purposively selected. The eligible hospitals should have facilities to provide standard T2DM inpatient services as required by clinical guidelines. Only hospitals with good quality medical records and those where hospital charge information could be extracted from hospital information system were selected. Three tertiary hospitals and three county hospitals were finally chosen. All consecutive inpatients with a principle diagnosis of T2DM (ICD-10 codes: E11.2–E11.9) admitted into the sampled hospitals and discharged during the data collection period were recruited into this study. Those who stayed in hospital for less than 24 hours or could not communicate by themselves were excluded. Finally, a total of 771 eligible participants were recruited into this study.

Table 1 shows the characteristics of surveyed hospitals.

Table 1. Characteristics of the surveyed hospitals.

Surveyed
hospital
LocationHospital levelBeds*Number of DM
inpatients per
year**
Sample
size
1CentralTertiary18911020184
2WesternTertiary22001000180
3EasternTertiary2000954170
4CentralCounty420248101
5WesternCounty38215059
6EasternCounty35017077

* Data were obtained from yearly statistical data of each hospital.

** Data were extracted from the hospital information system (HIS) of each hospital.

Variables

Outcome variables. The outcome variable of this study was treatment schemes of T2DM inpatients, which were classified into three categories: lifestyle management, oral therapy and insulin therapy, according to China’s treatment guideline for T2DM.

Explanatory variables. Socio-demographic variables (age, gender, ethnicity, marital status, occupation, residence, education, yearly income and expenditure, insurance scheme), disease characteristics variables (duration of T2DM, Age-adjusted Charlson Comorbidity Index (ACCI) score, diagnosis, participation in treatment planning), and institutional variables (hospital level, location of hospital and hospital reform status) were considered as explanatory variables for treatment schemes of T2DM inpatients.

Data collection and measurement

Patient interview data and medical records were collected and analyzed. Patient interviews were conducted one day before the patients were discharged using a questionnaire administered by well-trained research assistants. One week after the interview, the patients’ final medical records were reviewed by two researchers using a self-designed medical record review form. Both the patient interview questionnaire and the medical review forms were pre-tested in a pilot study for validation. A standard operating procedure was generated to standardize the data collection process.

Socio-demographic variables and two clinical variables (duration of T2DM and participation in treatment planning) were collected by patient interview, the other variables were extracted from the medical records.

Duration of T2DM was calculated by asking a patient the exact year when he/she was first diagnosed as T2DM by a clinician. ACCI scores were calculated automatically using an online calculator, with scores ranging from 0–37. The calculation was done by adding the weighted scores for 19 medical conditions. High scores are associated with a poorer prognosis21. Diagnosis was coded as T2DM, T2DM with complications, T2DM with comorbidities, and T2DM with complications and comorbidities. Patient participation in treatment planning was determined by asking patients: “Did the doctors discuss your treatment plan with you before they made a decision?” Hospital reform status was confirmed with the local government. Only the hospital which had implemented the reform policies (including Zero mark-up on part of essential medicines and clinical pathway for T2DM) was defined as reformed hospital. Two of the surveyed county hospitals were assigned as pilot hospital of hospital reform under the framework of national medical reform, however, both of them were coded as non-reformed hospitals for having not started reform yet.

Statistical methods

Data were presented as percentages for categorical variables or means for continuous variables. Multinomial logistic regression was used to explore the factors associated with treatment schemes. Weights were used to adjust the estimates due to cluster sampling. The strength of the association between factors and treatment scheme were presented as relative risk ratios (RRR) and 95% confidence intervals (95% CI). A P-value of less than 0.05 was considered as statistically significant. Data analysis was performed using the survey package of R software version 3.0.3 and Stata version 10.0.

Ethical considerations

This study was approved by the Institutional Review Board of the Faculty of Medicine, Prince of Songkla University, Thailand. Permission was obtained from surveyed hospitals and written informed consent was obtained from each participant before enrollment in the study. No incentives or financial payments were provided for the interviewed patients. Personal identification was removed from the completed questionnaires and confidentiality was assured.

Results

Comparison of treatment schemes based on T2DM inpatients’ socio-demographic characteristics

Social-demographic characteristics of participants and their treatment schemes are shown in Table 2. 80% of T2DM inpatients were aged 50 years and above. 6.4% attained a bachelor degree study or above. Minority groups were rare (3.7%). More than half of the participants (59.5%) were living in urban areas. Although the national health insurance system (urban employee’s insurance scheme, urban resident’s insurance scheme and new rural cooperative medical system) covered most of the participants, 21.2% of the participants covered the cost of their hospitalization.

Table 2. Comparison of treatment schemes based on T2DM inpatients’ socio-demographic characteristics (%).

VariablesTotalLifestyle
management
Oral
Therapy
Insulin
therapy
P value
Gender
     Female50.163.851.647.3 0.03
     Male49.936.248.452.7
Age group (years)
     <5020.013.816.421.80.05
     50–5928.217.829.429.8
     60–6930.447.233.926.7
     ≥7021.421.220.221.7
Education
     Illiterate20.532.016.519.30.32
     Primary school18.114.924.817.2
     High school54.948.051.956.8
     Bachelor or above6.55.26.86.7
Ethnicity
     Han96.397.794.496.50.53
     Minority3.72.35.63.5
Occupation
     Unemployed55.158.057.454.20.71
     Retired21.224.721.220.6
     Employed23.717.321.425.3
Marital status
     Married88.887.491.888.40.50
     Single/separated/widowed/divorced11.212.48.211.6
Household yearly income (Yuan)
     <2000029.332.135.027.70.50
     20000–4000023.931.614.624.4
     40000–6000018.512.519.619.2
     >6000028.323.730.828.6
Household yearly expenditure (Yuan)
     <2000034.70.4439.132.10.50
     20000–4000032.023.726.234.7
     40000–6000016.419.319.915.2
     >6000016.812.514.718.0
Location
     Rural areas40.549.645.837.80.37
     Urban areas59.550.454.262.2
Payers
     Uninsured21.217.911.523.80.49
     UEIS33.428.933.134.2
     URIS13.215.012.113.1
     NRCMS31.136.242.827.7
     Other insurance1.22.10.61.1

UEIS: Urban employee’s insurance scheme

URIS: Urban resident’s insurance scheme

NRCMS: New rural cooperative medical system

Treatment schemes significantly differed between genders. Females were more likely to be given lifestyle management and oral therapy, whereas males were more likely to be given insulin therapy. Lifestyle management and oral therapy were mostly given to those aged 60–69, those aged 50–59 were more likely to be given insulin therapy, however, the p-value was just on the cut point of statistical significance.

Comparison of treatment schemes based on T2DM inpatients’ clinical characteristics

Table 3 shows treatment schemes in relation to T2DM inpatients’ clinical characteristics. Diagnosis was significantly associated with treatment schemes. Those with comorbidities were more likely to be given lifestyle management and oral therapy than those with other clinical types, whereas those with complications and comorbidities were more likely to be given insulin therapy. The average duration of T2DM was 7.3 years (SE=0.5) and the mean ACCI score was 5.0 (SE=0.5). Physicians discussed with most of T2DM inpatients (85%) when they planned the treatment scheme for them.

Table 3. Comparison of treatment schemes based on T2DM inpatients’ clinical characteristics (%).

VariablesTotalLifestyle
management
Oral
Therapy
Insulin
therapy
P value
Diagnosis
     Simple T2DM2.70.01.43.5 0.01
     T2DM + complication3.92.13.24.3
     T2DM + comorbidity54.086.565.745.8
     T2DM + complication + comorbidity39.411.429.646.3
Duration of T2DM (years)
     Mean(SD)7.3(0.5)6.6(0.7)5.6(0.9)7.8(0.4)0.31
ACCI scores
     Mean(SD)5.0(0.5)4.9(0.2)5.0(0.4)5.1(0.6)0.75
Participation in treatment planning
     Yes85.086.584.684.90.94
     No15.013.515.415.1

Comparison of treatment schemes based on hospital characteristics

Table 4 shows the T2DM inpatient treatment schemes in different hospitals. Treatment schemes for T2DM inpatients differed in hospitals located in different regions. Lifestyle management and oral therapy were given more in the Eastern region, whereas insulin therapy was given more in the Western and central regions. Since there were no county hospitals served as pilot hospital for medical reform when we conducted this survey, hospital level and reform status were combined into one category variable to be analyzed. In the tertiary hospitals, which were not involved in medical reform, insulin therapy was common, whereas in the tertiary hospital with reform, oral therapy was used most. County hospital gave T2DM inpatients lifestyle management more frequently than medication. However, all the differences above were not statistically significant.

Table 4. Comparison of T2DM inpatient treatment schemes by hospital characteristics (%).

TotalLifestyle
management
Oral
therapy
Insulin
therapy
P value
Hospital location
     Western33.319.022.038.20.07
     Eastern33.346.559.125.6
     Central33.334.518.836.2
Hospital reform status
     Tertiary hospitals without reform16.33.512.219.40.47
     Tertiary hospitals with reform32.633.536.531.6
     County hospitals51.163.051.349.0

Hospital and patient factors associated with treatment schemes given to T2DM inpatients

Table 5 summarizes the results of a multivariate analysis for hospital and patient factors associated with treatment schemes given to T2DM inpatients. After controlling for patients’ clinical characteristics and payers, both hospital and patient level variables were associated with treatment schemes. Males were more likely to be given oral therapy (RRR = 1.72) and insulin therapy (RRR = 1.94) than females. Compared to other clinical types, those with comorbidities were less likely to be given insulin therapy (RRR = 0.16). Compared with the Western region, hospitals in central regions of Inner Mongolia were less likely to give T2DM inpatients oral therapy (RRR = 0.18) and insulin therapy (RRR = 0.20) than lifestyle management. Compared with tertiary hospitals without doing any healthcare reform, tertiary hospitals with reform and county hospitals were less likely to give T2DM inpatients oral therapy (RRR = 0.07 and 0.1 respectively) and insulin therapy (RRR = 0.11 and 0.17 respectively).

Table 5. Hospital and patient factors associated with treatment schemes given to T2DM inpatients.

Oral therapyInsulin therapy
RRR95% CIPRRR95% CIP
Individual level variables
Gender(Ref.=Female)
     Male1.721.06–2.81 0.04 1.941.29–2.91 0.01
Diagnosis(Ref.= Other clinical types)
     T2DM with comorbidity0.300.08–1.130.070.160.06–0.44 0.01
Duration of T2DM 0.980.94–1.030.371.030.99–1.080.13
ACCI score 0.950.81–1.120.490.890.72–1.090.19
Payers(Ref.= uninsured)
     UEIS0.810.13–5.200.790.580.07–5.150.55
     URIS0.780.07–8.280.800.950.04–20.260.97
     NRCMS1.170.21–6.480.830.620.12–3.260.49
     Other insurance0.200.01–6.690.300.310.01–15.80.48
Hospital level variables
Hospital location(Ref.= Western region)
     Hospital located in eastern region1.390.41–4.710.520.370.12–1.090.06
     Hospital located in central region0.180.05–0.61 0.02 0.200.06–0.67 0.02
Hospital reform status(Ref.= tertiary hospital without reform)
     Tertiary hospital with reform0.070.02–0.31 0.01 0.110.02–0.50 0.01
     County hospital0.100.02–0.58 0.02 0.170.03–0.94 0.04

UEIS: Urban employee’s insurance scheme

URIS: Urban resident’s insurance scheme

NRCMS: New rural cooperative medical system

RRR: relative risk ratio. Reference outcome group = lifestyle management

CI: confidence interval

idclitppacatcciscoreamaleptreatweightagegredu1oc1ethnimarital1incomegrexpendgrdmdurapayer1hoslevellocathosrefoutcome3gr
13080037.8550722000123100202
231120037.85507232101332410202
32030037.8550720200122500202
43150137.85507222201211010202
53121137.85507203201331000202
63180137.8550722200112700202
73181137.85507202211211210202
83161137.8550722210122010201
93151137.8550720200133100202
103131137.85507213201111010202
113170137.8550721210122010202
123160137.85507212101101510202
132181137.85507223201221010202
143140137.8550720201122030201
153070137.8550720200100830202
163171137.85507212101331510202
173171137.85507213101311710202
1831100037.8550722120111410200
193191137.85507232101001610202
2031110137.85507213101331010202
2131101137.85507212101221010202
223190037.85507222101213010202
233140037.8550720320132000202
243010137.8550720100110740202
2531100137.8550722111111310202
2631100137.85507232101113110202
273121037.8550720320121500202
283161137.8550720320133610202
2931111137.85507222101331510202
303120137.8550720200133810202
313060137.8550721210113310202
323191137.8550721320132010202
3330120137.8550723200001700202
343090137.8550721100102610202
353170137.8550721210133110202
363181137.8550720320133010200
373191137.85507222101331310202
383180137.8550720321133010202
393160137.8550722210133910202
403171137.8550721320133010202
413171137.8550721220132040202
423170037.85507222101221110202
4331101137.8550721321133210202
443180137.85507220200111410202
453061037.85507212201111710202
463150137.8550722200111720202
473191037.8550723210110800202
483161037.8550720320122310202
493190037.8550722210133640201
503190137.85507231101032300202
5131110137.85507232101331940202
522130137.8550721220121010201
532160137.8550722320133310201
543170037.85507210101111500202
553171137.8550720320133510202
563081037.8550721000101010202
573181137.8550721220133410202
583060037.85507212101331300202
593121137.8550720320133010202
602070137.85507222001321610202
613151137.8550721220111210202
623171137.85507213201221410202
633060037.85507220001011200202
642030137.8550720200110000202
653191037.8550721220123010202
663141137.8550721220122410202
672160137.8550720220122010200
683180037.8550721310133710202
693191137.8550721220133310201
703170137.85507213111331010201
713071137.8550720200133500202
7231100137.85507222100102010202
7330100137.8550721101000600202
7431100137.85507232001211300202
7530110137.85507230100101000202
763180137.85507222000111200202
773191137.85507212201221210202
783171137.8550723210122010202
793171137.8550720220123410202
8031101137.85507223111331010202
813171137.8550720320132810202
823150137.85507222100101010202
833160137.85507212200221010202
843181137.8550722210122710202
853151137.8550721320133410202
863160037.8550721210011510201
873181037.8550722210121620201
883181137.8550720220100010201
893161137.85507202001011110202
903161037.85507202201111710202
913181037.85507222101321810202
9231120037.85507233110212110202
933181137.85507223101321510202
9431121037.85507233211221710202
953191037.85507222101321310202
963141137.8550720220111110201
9731110037.85507231101332800202
9830101037.8550722210121900202
9931100137.8550721211011710201
1003040137.85507211010011300202
10130120037.8550722201133030202
1023151037.8550720221133010202
1033191137.85507230100111310202
1043180137.8550723210133810202
1053170037.85507233200331010202
1063150037.85507233200331010202
1073190137.85507221101221110202
1083160037.85507202101331410202
1092120137.8550720201132510202
11031110137.85507233100202110202
11131101137.85507223101331510202
1123151137.8550720320133510202
1133171137.85507213201331310202
11431110137.85507231001211520202
1153181137.8550721220133310201
11631110137.85507222101211110202
11730100137.8550723000102810202
1183170137.8550720200122200202
1193161137.8550721220133710202
1203160137.8550721110132510202
12131110137.85507223101331040202
1221130137.8550721220133300202
12331100137.8550722320133510202
1243150137.8550722210122100201
1253181137.8550722210133510202
12631101137.8550720320133700202
1273180137.8550721210033700202
1283160037.8550721200121010202
1293191137.8550721220133600202
1303061137.8550720221133200202
1313191137.85507212201322600202
1323171137.85507202200231010202
1333160137.8550722210122010202
1343141137.85507202201331010202
1353181037.8550720220133840202
1363161037.8550721120133120202
1373171037.8550722210033010201
1383161137.8550720220133010202
1392120072.0264030020011521200
1400121172.02640312201111811202
1413170172.0264032210130021202
1422040172.0264032000100031202
1432080172.0264032000100031200
1442080172.0264031100100621201
1453160172.02640322001112321202
1462040172.02640321001001201202
1472040172.0264032000100931202
1482141172.02640322101001311201
1492140172.02640332101122421202
1502030172.0264032100101901201
1512131172.0264031220111211202
1522040172.0264032000112031202
1532080172.0264032000112031200
1543180172.0264031010100421200
1553050172.02640330000011731200
1560111172.0264030200121201202
1572040172.0264032000110431200
1582070172.0264032000100531200
1593170172.02640330001011321202
1602140172.0264032000110031202
1612041172.0264032200111521200
1622031172.02640322001101031200
1632021172.0264030220120001202
1642040172.0264032000121431202
1652141172.0264030220110101202
1663170172.0264032200110801202
1672140172.0264032210110321202
1682131172.0264031220110001202
1692040172.02640330001001201201
1702050172.0264033200120931202
1712161172.02640322101301811202
17221101172.0264031210111021202
1732130172.02640311101001031202
1743171172.0264031200132001202
1753051172.02640302001101301202
1763131172.0264030320121711202
1773130172.0264030200100321202
1782061172.02640322001201031202
1793050172.0264032000100301202
1803150172.02640322101111311202
1812030172.0264031200111001202
1822111172.0264030220133521202
1832150172.0264032210112821202
1841141172.02640302201211301202
1850131172.02640322101111901202
1860030172.02640320001102031202
1872170172.02640322101222011200
1881151172.02640330001001321202
1892151172.0264030220131401200
1902181172.02640322101111001200
1913161172.02640322101111021202
1922121172.0264030220110721200
1932151172.02640332101101511200
1943141172.0264033210021321202
1952051172.02640332000111201202
1963061172.02640332001301101202
1972030172.0264031000120001202
1982031172.02640322001001231202
1991151172.02640330001001521202
This is a portion of the data; to view all the data, please download the file.
Dataset 1.Raw data of hospital and patient influencing factors on treatment schemes given for type 2 diabetes mellitus in patients in Inner Mongolia.
The raw data of influencing factors on treatment schemes are provided.

Discussion

After controlling for clinical conditions such as duration of disease, ACCI score and diagnosis, the hospital level factor stood out of all the potential explanatory variables. Hospital location, reform status and hospital level were associated with treatment scheme for T2DM inpatients significantly, while gender was the only demographic variable related.

Compared with the Western region, T2DM patients treated in the central regions of Inner Mongolia were more likely to be given lifestyle management than medication. As one of the major causes for healthcare disparities, geographic variations in treatment pattern of T2DM have been reported in other studies22. However, the underlying reasons of the variations were not always the same23. There might be two possible explanations for regional variations in this study. First, the Western region in Inner Mongolia has a lower population density compared with the central region (23 person/km2 vs 174 person/km2). Since a general practice system has not been fully set up in China, especially in Inner Mongolia, inferior accessibility to healthcare may reduce the healthcare seeking behavior of T2DM patients, which will cause them to lose the opportunity for early treatment. Second, hospitals in the same region have more chance to have professional and academic exchanges and learn from each other under the circumstance of lacking clinical pathway management. More evidences are needed to get the precise information on the factors contributing to the variations so that policies could be designed accordingly.

In this study we show that implementation of reform was associated with controlling medication use for T2DM patients. Reformed tertiary hospitals were less likely to give T2DM patients medication treatment compared to tertiary hospitals without any reform. The public hospital reform in China under the national healthcare reform framework started from tertiary hospitals24. In the first stage of the reform, enhancing internal management was carried out by many hospitals to improve the quality of care. Zero mark-up on part of essential medicines (A zero-profit drug policy introduced by China government from the year 2009 to remove the mark-up for medicines sale in hospitals. The major objective of this policy was to reduce the incentive for providers to prescribe unnecessary drugs25.), and clinical pathway for T2DM were implemented in the reformed hospitals of this study. Although the hospitals had set out to implement the reform for less than three years when this survey was conducted, a series of policies was generalized and experimented by the hospitals to match the requirement of the government. Some studies report that the zero mark-up policy can decrease drug prescriptions and reduce total expense for both outpatient and inpatient services26,27. Clinical pathway has been shown to reduce the variability in clinical practices28. However, further studies are needed to confirm the causation between the reform and the change in physicians’ clinical practices.

Among non-clinical characteristics, major gender differences in the treatment schemes given to T2DM patients were observed in this study. Males were more likely to be given oral therapy and insulin therapy than females who were mostly given lifestyle management. Many studies have revealed the fact that females have increased adherence to preventive practices29, and males have lower obedience to diet control and exercise30. However, gender differences in treatment protocols lead to unequal treatment and it should be avoided as much as possible. One way this can be done is by incorporating patient preferences into the treatment schemes. Systematic reviews done on the patient preferences for non-insulin diabetes medications during 2007–201231,32 have shown the importance of incorporating patient preferences into treatment decisions. These reviews showed that the key attributes of diabetes medication associated with patient preferences include treatment benefits (e.g. glycemic control and weight loss/control), treatment burden (e.g. administration, frequency, and cost), and side effects (e.g. weight gain, gastrointestinal effects, and hypoglycemia)31. Therefore, gender differences in the treatment schemes can be allowed as long as they accommodate the patient’s preferences and treatment efficacy is not compromised.

A number of studies have found evidence about health disparities in different ethnic groups33,34. However, ethnicity was not significantly associated with treatment schemes in this study. If we look at the distribution of ethnicity among T2DM inpatients, it was quite different from that of the whole population of Inner Mongolia. Our findings showed that minority groups with T2DM were rare (3.7%) across the six hospitals studied. This proportion was much lower than in the whole population of Inner Mongolia (21%). This could be because minorities prefer traditional medicine to Western medicine. However, further studies are needed to obtain information about accessibility and utilization of healthcare for minority groups with T2DM in Inner Mongolia. Where ethnic and racial disparities exist in the treatment of diabetes patients, it is evident that policy responses for addressing minority groups are needed.

Education level was low among T2DM patients in this study. Only 6.5% of T2DM patients had attained a bachelor degree or above, which was lower than the whole population (10.3%). Education has been found to be associated with all aspects of T2DM treatment including prevention, outpatient care, inpatient care, and rehabilitation29,35. However, other studies have put forward evidence that the educational level of patients had no association with untreated diabetes36 or with the prevalence of diabetes37. Although the possibilities for disparities in treatment types may exist by level of education, this study did not find any association between education level and the type of treatment schemes that was given to the patients.

This study also found that although the national health insurance system covered most (77.6%) of the participants, 21.2% of the participants had no insurance. In contrast, among all adults with diabetes in the USA, 92.0% had some form of health insurance38. Physicians usually have different personal attitudes toward insured and uninsured patients. This was demonstrated in an analysis of patients who were insured which showed that they had a higher number of prescribed medications, and a higher total price of prescription than those who paid cash only39. It has been found that even insurers have major differences in attitude with regard to diabetes. Some patients who had declared their disease status to the insurers were refused acceptance for insurance and for some, their premiums were increased40. These evidences prove the importance of state mandated insurance programs, especially for diseases such as T2DM which has a long treatment period.

Strengths and limitations

This was a hospital-based study using combined methods of patient interview and hospital record review to obtain clinical and non-clinical data, which can eliminate the recall bias on health service experience inherent in population based surveys. However, several limitations in this study should be acknowledged. First, it was a hospital-based study, therefore the findings cannot be generalized to the whole population of China, or T2DM patients. Second, due to the cross-sectional nature of the study, causality of certain risk factors and the study outcome cannot be established. Third, we did not measure all potential patient risk factors, such as hemoglobin A1C values, which were not available. As such, duration of T2DM, diagnosis and ACCI score were used to estimate severity of disease, which are known to be less precise. Fourth, physicians’ characteristics (such as age, how long they were certified, etc.) were not available, which would be a factor in determining treatment and adherence to the national guidelines.

Conclusion

In conclusion, this study did not show any socio-demographic factors except gender influencing the treatment patterns for T2DM inpatients, independently of their clinical condition. Hospitals from different regions have different treatment patterns, which tends to increase the healthcare disparities and should be eliminated by exploring further policy strategies. Implementation of reform was shown to be associated with controlling medication use for T2DM inpatients. However, the causation between the reform and changing of physicians’ clinical practices should be explored in further studies.

Data availability

F1000Research: Dataset 1. Raw data of hospital and patient influencing factors on treatment schemes given for type 2 diabetes mellitus in patients in Inner Mongolia, 10.5256/f1000research.9095.d12782541

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 05 Jul 2016
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Zhang N, McNeil E, Assanangkornchai S and Fan Y. Hospital and patient influencing factors of treatment schemes given to type 2 diabetes mellitus inpatients in Inner Mongolia, China [version 1; peer review: 2 approved]. F1000Research 2016, 5:1577 (https://doi.org/10.12688/f1000research.9095.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 05 Jul 2016
Views
11
Cite
Reviewer Report 12 Jul 2016
Jian Wang, Department of Social Medicine and Administration, Shandong University, Jinan, China 
Approved
VIEWS 11
This is a policy-relevant article to study hospital and patient factors influencing T2DM treatment in Mongolia. The rapid increasing of T2DM gives a pressure to the health system in Inner Mongolia. The authors are interested in exploring health care disparities ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Wang J. Reviewer Report For: Hospital and patient influencing factors of treatment schemes given to type 2 diabetes mellitus inpatients in Inner Mongolia, China [version 1; peer review: 2 approved]. F1000Research 2016, 5:1577 (https://doi.org/10.5256/f1000research.9789.r14809)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
13
Cite
Reviewer Report 11 Jul 2016
Stephen Nicholas, Newcastle Business School, The University of Newcastle, Newcastle, NSW, Australia 
Approved
VIEWS 13
The paper briefly sets out on page 3 the nature of equity issues in hospital health care and the problems of measuring health care disparities, especially from the clinical side. Using a transitional and developing region of China, Inner Mongolia, ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Nicholas S. Reviewer Report For: Hospital and patient influencing factors of treatment schemes given to type 2 diabetes mellitus inpatients in Inner Mongolia, China [version 1; peer review: 2 approved]. F1000Research 2016, 5:1577 (https://doi.org/10.5256/f1000research.9789.r14808)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 05 Jul 2016
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.